nach oben

Current Cardiology Reports

Erschienen in:

01.02.2016 | Ischemic Heart Disease (D Mukherjee, Section Editor)

Angina Pectoris and Myocardial Ischemia in the Absence of Obstructive Coronary Artery Disease: Role of Diagnostic Tests

verfasst von: Gaetano Antonio Lanza

Erschienen in: Current Cardiology Reports | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Patients with chest pain and nonobstructive coronary artery disease (NO-CAD) at angiography constitute a heterogeneous population. In most patients with stable exercise-induced chest pain, microvascular angina (MVA) is the likely diagnosis. Some clinical findings and results of diagnostic tests suggest that angina is caused by coronary microvascular (CMV) dysfunction rather than obstructive CAD, but a definitive diagnosis requires demonstration of impaired CMV dilation and/or increased constriction. About 10 % of patients presenting with an acute coronary syndrome also shows NO-CAD at angiography, and CMV constriction can be responsible for the syndrome in a number of cases. Diagnostic tests are not expected to have a prognostic role in patients with stable MVA with normal coronary arteries, due to the excellent prognosis of these patients, whereas their prognostic role in the more general population of NO-CAD patients with chest pain (either stable or acute) needs to be established in adequate studies.

Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362:886–95.PubMedCentralCrossRefPubMed

2.••

Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015;131:861–70. A review of studies about features and outcome of patients with acute coronary syndromes and non obstructive coronary atherosclerosis.CrossRefPubMed

Lanza GA. Cardiac syndrome X: a critical overview and future perspectives. Heart. 2007;93:159–66.PubMedCentralCrossRefPubMed

Cannon 3rd RO, Epstein SE. “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988;61:1338–43.CrossRefPubMed

Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010;121:2317–25.CrossRefPubMed

Cannon 3rd RO. Microvascular angina. Cardiovascular investigations regarding pathophysiology and management. Med Clin North Am. 1991;75:1097–118.PubMed

7.•

Ong P, Athanasiadis A, Borgulya G, Vokshi I, Bastiaenen R, Kubik S, et al. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation. 2014;129:1723–30. A large study about the effects of intracoronary acetylcholine in patients with chest pain and non obstructive coronary atherosclerosis.CrossRefPubMed

Weiner DA, McCabe C, Hueter DC, Ryan TJ, Hood Jr WB. The predictive value of anginal chest pain as an indicator of coronary disease during exercise testing. Am Heart J. 1978;96:458–62.CrossRefPubMed

Di Franco A, Milo M, Laurito M, Nerla R, Lanza GA. Comparisons of clinical and angina characteristics between patients with cardiac syndrome X and patients with coronary artery disease. It J Practice Cardiol. 2012;1:15–21. www.ancecardio.it.

10.

Pupita G, Kaski JC, Galassi AR, Gavrielides S, Crea F, Maseri A. Similar time course of ST depression during and after exercise in patients with coronary artery disease and syndrome X. Am Heart J. 1990;120:848–54.CrossRefPubMed

11.

Burton P, Kaski JC, Maseri A. A combination of electrocardiographic methods represents a further step toward the noninvasive identification of patients with syndrome X. Am Heart J. 1992;123:53–8.CrossRefPubMed

12.

Kaski JC, Crea F, Nihoyannopoulos P, Hackett D, Maseri A. Transient myocardial ischemia during daily life in patients with syndrome X. Am J Cardiol. 1986;58:1242–7.CrossRefPubMed

13.

Lanza GA, Stazi F, Colonna G, Pedrotti P, Manzoli A, Crea F, et al. Circadian variation of ischemic threshold in syndrome X. Am J Cardiol. 1995;75:683–6.CrossRefPubMed

14.

Lanza GA, Manzoli A, Bia E, Crea F, Maseri A. Acute effects of nitrates on exercise testing in patients with syndrome X. Clinical and pathophysiological implications. Circulation. 1994;90:2695–7009.CrossRefPubMed

15.

Radice M, Giudici V, Pusineri E, et al. Different effects of acute administration of aminophylline and nitroglycerin on exercise capacity in patients with syndrome X. Am J Cardiol. 1996;78:88–90. TC.CrossRefPubMed

16.•

Russo G, Di Franco A, Lamendola P, Tarzia P, Nerla R, Stazi A, et al. Lack of effect of nitrates on exercise stress test results in patients with microvascular angina. Cardiovasc Drugs Ther. 2013;27:229–34. A study that shows the different effects of preventive nitrates on exercise stress test in patients with chronic stable angina and microvascular angina.CrossRefPubMed

17.

Kaul S, Newell JB, Chesler DA, Pohost GM, Okada RD, Boucher CA. Quantitative thallium imaging findings in patients with normal coronary angiographic findings and in clinically normal subjects. Am J Cardiol. 1986;57:509–12.CrossRefPubMed

18.

Cavusoglu Y, Entok E, Timuralp B, Vardareli E, Kudaiberdieva G, Birdane A, et al. Regional distribution and extent of perfusion abnormalities, and the lung to heart uptake ratios during exercise thallium-201 SPECT imaging in patients with cardiac syndrome X. Can J Cardiol. 2005;21:57–62.PubMed

19.

Diamond JA, Makaryus AN, Sandler DA, Machac J, Henzlova MJ. Normal or near normal myocardial perfusion stress imaging in patients with severe coronary artery disease. J Cardiovasc Med (Hagerstown). 2008;9:820–5.CrossRef

20.

Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A. Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X. Am J Cardiol. 1987;60:508–12.CrossRefPubMed

21.

Nihoyannopoulos P, Kaski JC, Crake T, Maseri A. Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol. 1991;18:1463–70.CrossRefPubMed

22.

Panza JA, Laurienzo JM, Curiel RV, Unger EF, Quyyumi AA, Dilsizian V, et al. Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. J Am Coll Cardiol. 1997;29:293–301.CrossRefPubMed

23.

Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 1991;17:499–506.CrossRefPubMed

24.

Elhendy A, Geleijnse ML, Roelandt JR, van Domburg RT, TenCate FJ, Cornel JH, et al. Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress? J Am Coll Cardiol. 1996;27:323–9.CrossRefPubMed

25.

Fragasso G, Chierchia SL, Lu C, Dabrowski P, Pagnotta P, Rosano GM. Left ventricular dysfunction during dobutamine stress echocardiography in patients with syndrome X and positive myocardial perfusion scintigraphy. G Ital Cardiol. 1999;29:383–90.PubMed

26.

Cadeddu C, Nocco S, Deidda M, Pau F, Colonna P, Mercuro G. Altered transmural contractility in postmenopausal women affected by cardiac syndrome X. J Am Soc Echocardiogr. 2014;27:208–14.CrossRefPubMed

27.

Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359:2324–36.CrossRefPubMed

28.

Joye JD, Schulman DS. Clinical application of coronary flow reserve using an intracoronary Doppler guide wire. Cardiol Clin. 1997;15:101–29.CrossRefPubMed

29.

Pijls NH, De Bruyne B, Smith L, Aarnoudse W, Barbato E, Bartunek J, et al. Coronary thermodilution to assess flow reserve: validation in humans. Circulation. 2002;105:2482–6.CrossRefPubMed

30.

Jerosch-Herold M, Seethamraju RT, Swingen CM, Wilke NM, Stillman AE. Analysis of myocardial perfusion MRI. J Magn Reson Imaging. 2004;19:758–70.CrossRefPubMed

31.

Kaufmann PA, Camici PG. Myocardial blood flow by PET: technical aspects and clinical applications. J Nucl Med. 2005;46:75–88.PubMed

32.

Bøttcher M, Botker HE, Sonne H, Nielsen TT, Czernin J. Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X. Circulation. 1999;99:1795–801.CrossRefPubMed

33.

de Vries J, DeJongste MJ, Jessurun GA, Jager PL, Staal MJ, Slart RH. Myocardial perfusion quantification in patients suspected of cardiac syndrome X with positive and negative exercise testing: a [13N] ammonia positron emission tomography study. Nucl Med Commun. 2006;27:791–4.CrossRefPubMed

34.

Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346:1948–53.CrossRefPubMed

35.

Lanza GA, Buffon A, Sestito A, Natale L, Sgueglia GA, Galiuto L, et al. Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol. 2008;51:466–72.CrossRefPubMed

36.

Grayburn PA. “Product safety” compromises patient safety (an unjustified black box warning on ultrasound contrast agents by the Food and Drug Administration). Am J Cardiol. 2008;101:892–3.CrossRefPubMed

37.

Meimoun P, Tribouilloy C. Non-invasive assessment of coronary flow and coronary flow reserve by transthoracic Doppler echocardiography: a magic tool for the real world. Eur J Echocardiogr. 2008;9:449–57.CrossRefPubMed

38.

Hozumi T, Yoshida K, Akasaka T, Asami Y, Ogata Y, Takagi T, et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol. 1998;32:1251–9.CrossRefPubMed

39.

Saraste M, Koskenvuo J, Knuuti J, Toikka J, Laine H, Niemi P, et al. Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol. 2001;21:114–22.CrossRefPubMed

40.

Galiuto L, Sestito A, Barchetta S, Sgueglia GA, Infusino F, La Rosa C, et al. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol. 2007;99:1378–83.CrossRefPubMed

41.

Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ Res. 1980;47:807–13.CrossRefPubMed

42.

Wang T, Mentzer Jr RM, Van Wylen DG. Interstitial adenosine with dipyridamole: effect of adenosine receptor blockade and adenosine deaminase. Am J Physiol. 1992;263(2 Pt 2):H552–8.PubMed

43.

Prior JO, Schindler TH, Facta AD, Hernandez-Pampaloni M, Campisi R, Dahlbom M, et al. Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans. Eur J Nucl Med Mol Imaging. 2007;34:20–7.CrossRefPubMed

44.

Buchthal SD, den Hollander JA, Merz CN, Rogers WJ, Pepine CJ, Reichek N, et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med. 2000;342:829–35.CrossRefPubMed

45.••

Sestito A, Lanza GA, Di Monaco A, Lamendola P, Careri G, Tarzia P, et al. Relation between cardiovascular risk factors and coronary microvascular dysfunction in cardiac syndrome X. J Cardiovasc Med (Hagerstown). 2011;12:322–7. A study that shows the variable endothelium-dependent and endothelium-independent coronary microvascular impairment in patients with exercise induced angina and normal coronary arteries.CrossRef

46.

Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, et al. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol. 1997;29:308–17.CrossRefPubMed

47.

Lanza GA. Abnormal cardiac nerve function in syndrome X. Herz. 1999;24:97–106.CrossRefPubMed

48.

Cannon 3rd RO, Watson RM, Rosing DR, Epstein SE. Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol. 1983;1:1359–73.CrossRefPubMed

49.

Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:e354–471.CrossRefPubMed

50.

Fragasso G, Lauretta L, Busnardo E, Cera M, Godino C, Colombo A, et al. Prognostic role of stress/rest myocardial perfusion scintigraphy in patients with cardiac syndrome X. Int J Cardiol. 2014;173:467–71.CrossRefPubMed

51.

Alqaisi F, AlBadarin F, Jaffery Z, Tzogias L, Dawod M, Jacobsen G, et al. Prognostic predictors and outcomes in patients with abnormal myocardial perfusion imaging and angiographically insignificant coronary artery disease. J Nucl Cardiol. 2008;15:754–61.CrossRefPubMed

52.

Sicari R, Palinkas A, Pasanisi EG, Venneri L, Picano E. Long-term survival of patients with chest pain syndrome and angiographically normal or near-normal coronary arteries: the additional prognostic value of dipyridamole echocardiography test (DET). Eur Heart J. 2005;26:2136–41.CrossRefPubMed

53.

Britten MB, Zeiher AM, Schachinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis. 2004;15:259–64.CrossRefPubMed

54.

Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010;55:2825–32.PubMedCentralCrossRefPubMed

55.

Lamendola P, Lanza GA, Spinelli A, Sgueglia GA, Di Monaco A, Barone L, et al. Long-term prognosis of patients with cardiac syndrome X. Int J Cardiol. 2010;140:197–9.CrossRefPubMed

56.

Kaski JC, Rosano GMC, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol. 1995;25:807–14.CrossRefPubMed

57.

Lanza GA, Andreotti F, Sestito A, Sciahbasi A, Crea F, Maseri A. Platelet aggregability in cardiac syndrome X. Eur Heart J. 2001;22:1924–30.CrossRefPubMed

58.

Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169:843–50.PubMedCentralCrossRefPubMed

59.

Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33:734–44.CrossRefPubMed

60.

Sgueglia GA, Sestito A, Spinelli A, Cioni B, Infusino F, Papacci F, et al. Long-term follow-up of cardiac syndrome X patients treated by spinal cord stimulation. Heart. 2007;93:591–7.PubMedCentralCrossRefPubMed

61.

Cannon RO, Quyyumi AA, Schenke WH, et al. Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol. 1990;16:1359–66.CrossRefPubMed

62.

Pasceri V, Lanza GA, Buffon A, Montenero AS, Crea F, Maseri A. Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X. J Am Coll Cardiol. 1998;31:62–6.CrossRefPubMed

63.

Benjamin SB. Microvascular angina and the sensitive heart: historical perspective. Am J Med. 1992;92:52S–6S.CrossRefPubMed

64.

Di Monaco A, Lanza GA, Bruno I, Careri G, Pinnacchio G, Tarzia P, et al. Usefulness of impairment of cardiac adrenergic nerve function to predict outcome in patients with cardiac syndrome X. Am J Cardiol. 2010;106:1813–8.CrossRefPubMed

65.

Di Franco A, Villano A, Di Monaco A, Lamendola P, Russo G, Stazi A, et al. Correlation between coronary microvascular function and angina status in patients with stable microvascular angina. Eur Rev Med Pharmacol Sci. 2014;18:374–9.PubMed

66.

Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigators. N Engl J Med. 1999;341:226–32.CrossRefPubMed

67.

Patel MR, Chen AY, Peterson ED, et al. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. Am Heart J. 2006;152:641–7.CrossRefPubMed

68.

Lanza GA, Crea F. Acute coronary syndromes without obstructive coronary atherosclerosis: the tiles of a complex puzzle. Circ Cardiovasc Interv. 2014;7:278–81.CrossRefPubMed

69.

Beltrame JF, Limaye SB, Wuttke RD, Horowitz JD. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J. 2003;146:84–90.CrossRefPubMed

70.

Beltrame JF, Turner SP, Leslie SL, Solomon P, Freedman SB, Horowitz JD. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol. 2004;44:57–62.CrossRefPubMed

71.

Ohba K, Sugiyama S, Sumida H, Nozaki T, Matsubara J, Matsuzawa Y, et al. Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease. J Am Heart Assoc. 2012;1:e002485.PubMedCentralCrossRefPubMed

72.

Galiuto L, De Caterina AR, Porfidia A, Paraggio L, Barchetta S, Locorotondo G, et al. Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in apical ballooning or tako-tsubo syndrome. Eur Heart J. 2010;31:1319–27.CrossRefPubMed

73.

Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H, et al. Angina pectoris caused by coronary microvascular spasm. Lancet. 1998;351:1165–9.CrossRefPubMed

74.

Dokainish H, Pillai M, Murphy SA, DiBattiste PM, Schweiger MJ, Lotfi A, et al. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol. 2005;45:19–24.CrossRefPubMed

75.

Planer D, Mehran R, Ohman EM, White HD, Newman JD, Xu K, et al. Prognosis of patients with non-ST-segment elevation myocardial infarction and non-obstructive coronary artery disease: propensity matched analysis from the ACUITY trial. Circulation Cardiovasc Interv. 2014;7:285–93.CrossRef

Titel: Angina Pectoris and Myocardial Ischemia in the Absence of Obstructive Coronary Artery Disease: Role of Diagnostic Tests
verfasst von: Gaetano Antonio Lanza
Publikationsdatum: 01.02.2016
Verlag: Springer US
Erschienen in: Current Cardiology Reports / Ausgabe 2/2016
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-015-0688-3

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2016

Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure

Interventional Options for Coronary Artery Calcification

Nuclear Imaging Guidance for Ablation of Ventricular Arrhythmias

Role of Cardiac CT Before Transcatheter Aortic Valve Implantation (TAVI)